Effect of delayed initiation of gonadotropin in luteal long protocol on in vitro fertilization

Gynecological Endocrinology

Volumn 29, Issue 9, 2013, Pages 846-850

  Lin, Haiyan ^a   Li, Yu ^a   Li, Lin ^a   Zhang, Qingxue ^a   Wang, Wenjun ^a   Chen, Xiaoli ^a   Yang, Dongzi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Delayed initiation; GnRH agonist; IVF

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; BIRTH RATE; BODY MASS; CLINICAL PROTOCOL; CONTROLLED STUDY; EMBRYO TRANSFER; ESTROGEN BLOOD LEVEL; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; GROUPS BY AGE; HORMONAL THERAPY; HUMAN; LIVE BIRTH; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NIDATION; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; THERAPY DELAY;

ADULT; CELL COUNT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPINS; HUMANS; INFERTILITY; LUTEAL PHASE; OVARIAN FOLLICLE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE;

EID: 84883353226     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.813475     Document Type: Article

References (14)

1. Alvarez C, Cremades N, Blasco N, et al. Influence of gonadotropinreleasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization. Hum Reprod 1997;12:2366-9
2. Chang SY, Lee CL, Wang ML, et al. No detrimental effects in delaying initiation of gonadotropin administration after pituitary desensitization with gonadotropin-releasing hormone agonist. Fertil Steril 1993;59:183-6
3. Damario MA, Moomjy M, Tortoriello D, et al. Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-A) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates. Fertil Steril 1997;68:1004-10
4. Antoine JM, Salat-Baroux J, Alvarez S, et al. Ovarian stimulation using human menopausal gonadotropins with or without LHRH analogues in a long protocol for in-vitro fertilization: A prospective randomized comparison. Hum Reprod 1990;5:565-9
5. Damario MA, Moomjy M, Tortoriello D, et al. Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-A) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates. Fertil Steril 1997;68:1004-10
6. Golan A, Weissman A. Symposium: Update on prediction and management of OHSS. A modern classification of OHSS. Reprod Biomed Online 2009;19:28-32
7. Ravhon A, Aurell R, Lawrie H, et al. The significance of delayed suppression using buserelin acetate and recombinant folliclestimulating hormone in a long protocol in vitro fertilization program. Fertil Steril 2000;73:325-9
8. Dessolle L, Ferrier D, Colombel A, et al. Prolonging GnRH-Agonist to achieve ovarian suppression does not compromise the results of a long protocol. Eur J Obstet Gynecol Reprod Biol 2011;159:111-4
9. Calhaz-Jorge C, Leal F, Cordeiro I, et al. Pituitary down-regulation in IVF cycles: Is it necessary to use strict criteria? J Assist Reprod Genet 1995;12:615-9
10. Hughers EG, Fedorkow DM, Daya S, et al. The routine use of gonadotropin releasing hormone agonists prior to in vitro fertilization and gamete intra fallopian transfer: A meta-Analysis of randomized studies. Fertil Steril 1992;58:888-96
11. Scott RT, Hayslip CA, Neal GS, et al. The duration of leuprolide acetate administration prior to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins. Fertil Steril 1993;60:247-53
12. Seifer DB, Thornton KL, DeCherney AH, Lavy G. Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success. Fertil Steril 1991;56:500-4
13. Polan ML, Daniele A, Russel JB, DeCherney AH. Ovulation induction with human menopausal gonadotropin compared to urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function. J Clin Endocrinol Metab 1986;63: 1284-91
14. Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 2002;17:3129-37